3020 Children's Way
San Diego, CA 92123
Rady Children's Specialists of San Diego
Duke University School of Medicine
Duke University School of Medicine
Duke University School of Medicine
University of Michigan Health Systems
Pediatric Hematology/Oncology, Pediatrics
Dr. Courtney Thornburg is the medical director of the Hemophilia and Thrombosis Treatment Center at Rady Children's Hospital-San Diego and the director of the Hemostasis and Thrombosis Research Program. She is also the director of the Hemostasis and Thrombosis Fellowship Program and a professor of clinical pediatrics at UC San Diego School of Medicine.
Dr. Thornburg graduated from Duke University Medical School, completed her pediatric residency at Duke University Medical Center, and completed her pediatric hematology/oncology fellowship at the University of Michigan, where she also earned a master's degree in clinical research design and statistical analysis. During her time in Michigan she focused her training on hemophilia and other bleeding disorders. From 2005-2013, Dr. Thornburg was on the faculty at Duke University, where she directed the sickle cell and hemostasis and thrombosis programs.
Dr. Thornburg is committed to taking care of children with blood disorders, including bleeding disorders, clotting disorders and inherited red blood cell disorders. She conducts clinical research to improve the care of children with blood disorders and is currently a principal investigator for multiple clinical trials and cohort studies including INITIATE and ATHN 8. To educate the next generation of physicians, Dr. Thornburg teaches medical students, residents and fellows.
Dr. Thornburg is a member of the American Society of Pediatric Hematology/Oncology, the American Society of Hematology, the International Society of Haemostasis and Thrombosis and the Hemophilia and Thrombosis Research Society. At Rady Children's, she is the lead physician for the Venous Thromboembolism Prevention Task Force.
In addition to her career in medicine, Dr. Thornburg enjoys spending time with her family, traveling and playing tennis.
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, SantamarÃa A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, KÃ¡llay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P, EINSTEIN-Jr Phase 3 Investigators.
Scurvy Findings in a Child with Jacobsen Syndrome: A Case Report.
Puddy AC, Hughes JL, Joffe AL, Khanna PC, Thornburg CD, Mubarak SJ
How we approach: Training pediatric coagulationists.
Thornburg CD, Montgomery RR, Pipe SW
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review.
Yu JK, Iorio A, Edginton AN, WAPPS coâ€investigators.
Your tired, your poor, your huddled masses.
Ware RE, Thornburg CD
Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia.
Croteau SE, Cheng D, Cohen AJ, Holmes CE, Malec LM, Silvey M, Thornburg CD, Wheeler AP, Kouides PA, Raffini LJ, Neufeld EJ
Novel Factor XIII variant identified through whole-genome sequencing in a child with intracranial hemorrhage.
Briggs B, James KN, Chowdhury S, Thornburg C, Farnaes L, Dimmock D, Kingsmore SF, RCIGM Investigators.
Identification and characterization of novel mutations implicated in congenital fibrinogen disorders.
Smith N, Bornikova L, Noetzli L, Guglielmone H, Minoldo S, Backos DS, Jacobson L, Thornburg CD, Escobar M, White-Adams TC, Wolberg AS, Manco-Johnson M, Di Paola J
Hematologic Manifestations of Nutritional Deficiencies: Early Recognition is Essential to Prevent Serious Complications.
Yu JC, Shliakhtsitsava K, Wang YM, Paul M, Farnaes L, Wong V, Kim J, Thornburg CD
Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations.
Moyer GC, Bannow BS, Thornburg C, Rosovsky R, Wang TF, Woller S, Thornhill D, Kreuziger LB
Risk factors for cardiovascular disease in children and young adults with haemophilia.
Limjoco J, Thornburg CD
Treatment adherence in hemophilia.
Thornburg CD, Duncan NA
A novel compound heterozygous form of severe protein C deficiency causing bleeding without purpura fulminans.
Herrick NL, Geddis AE, Lovejoy AE, Kim J, Schiff D, Thornburg CD
Venous Thromboembolism in Children with Cancer and Blood Disorders.
Ko RH, Thornburg CD
Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs.
Doshi A, Ryu J, Thornburg CD, Hershey D, Cherry R, Milligan K, Rosenzweig S, Leonard S
Initial Evaluation of the Pediatric PROMISÂ® Health Domains in Children and Adolescents With Sickle Cell Disease.
Dampier C, Barry V, Gross HE, Lui Y, Thornburg CD, DeWalt DA, Reeve BB
Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
Luchtman-Jones L, Pressel S, Hilliard L, Brown RC, Smith MG, Thompson AA, Lee MT, Rothman J, Rogers ZR, Owen W, Imran H, Thornburg C, Kwiatkowski JL, Aygun B, Nelson S, Roberts C, Gauger C, Piccone C, Kalfa T, Alvarez O, Hassell K, Davis BR, Ware RE
Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.
Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Jason Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter SD, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML, Rice HE, Splenectomy in Congenital Hemolytic Anemia Consortium.
Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life.
Anderson LM, Allen TM, Thornburg CD, Bonner MJ
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.
Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA, Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee.
From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia.
Hankins JS, Aygun B, Nottage K, Thornburg C, Smeltzer MP, Ware RE, Wang WC
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.
Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at email@example.com.